Picture of Yungjin Pharm Co logo

003520 Yungjin Pharm Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Annual cashflow statement for Yungjin Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line5,030-133-11,582-21,961-3,876
Depreciation
Amortisation
Non-Cash Items12,5318,81612,86724,10712,102
Unusual Items
Other Non-Cash Items
Changes in Working Capital-15,905-1,946-276-21,517-27,125
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities9,28314,4988,368-11,610-10,224
Capital Expenditures-10,358-6,305-11,320-13,200-10,238
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items21.6652-318-152-2,780
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-10,336-5,653-11,638-13,352-13,017
Financing Cash Flow Items-432-359-250-870-2,278
Other Financing Cash Flow
Net Issuance / Retirement of Debt
Cash from Financing Activities-128-9,0663,30725,18029,766
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1,182-22436.92186,525